Insitro partners with Lilly to advance AI-driven metabolic disease treatments
Endpoints News - 09-Oct-2024A collaboration to develop gene-silencing therapies for fatty liver disease
Eli Lilly and Company
American pharmaceutical company
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.
Visit website: https://www.lilly.com/
Details last updated 30-Apr-2020
Eli Lilly and Company News
The future of longevity: investing in the next biotech revolution
The Motley Fool - 13-Aug-2024How lifespan-extending drugs could shape the next biotech boom
Isomorphic Labs partners with Eli Lilly, Novartis to use AI in drug discovery
pharmaphorum - 08-Jan-2024Their AlphaFold engine models proteins could lead to faster and more effective treatments
Isomorphic labs teams up with pharma giants for AI-driven drug discovery
TechCrunch - 07-Jan-2024Eli Lilly and Novartis invest in cutting-edge AI to accelerate the search for life-saving treatments
Fauna Bio hunts for novel obesity drugs in $494m Lilly partnership
Longevity Technology - 21-Dec-2023Fauna's AI platform explores animal data to unlock breakthroughs in weight management
Donanemab slows Alzheimer’s disease in trial, but with serious side effects
New Scientist - 18-Jul-2023New Alzheimer's drug benefits early-stage patients; concern remain about affordability and serious risks
Genesis Therapeutics Lands AI Drug Discovery Deal with Eli Lilly
Endpoints News - 03-May-2022AI-driven biotech teams up with Lilly in a deal worth up to $670 million
Longevity Vision Fund joins Series B funding for Sigilon Therapeutics
Longevity Vision Fund - 20-Apr-2020To support human clinical trial of novel encapsulated cell therapy for hemophilia A
Alector raises 133 million to tackle neurodegenerative diseases
Biospace - 25-Jul-2018Advancing immune-based therapies for alzheimer’s and dementia
Personalised medicine and the ‘batch of you’
Silicon Republic - 30-Sep-2017FDA approved in 2017, Kymriah is entirely customised to the individual patient. Eight of the top...
Digital health pharma news from Q4 2016
MobiHealthNews - 13-Jan-2017Investment in digital tools to enhance data collection in clinical trials. Litmus Health using w...
Eli Lilly and Company Creations
People at Eli Lilly and Company
Andrew Adams
Co-director at Lilly Institutes for Genetic Medicine and SVP Neurodegeneration Research
